Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacodynamics Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01209351
What this trial is testing

Effect of Teduglutide on Gastric Emptying in Healthy Subjects

Who this might be right for
Healthy Volunteers
Shire 36
Very early researchEnded earlyNCT05517837
What this trial is testing

A Phase 1, First-in-Human Study of BMS-986421 in Healthy Participants

Who this might be right for
Healthy Participants
Bristol-Myers Squibb 46
Early research (Phase 1)Study completedNCT04082754
What this trial is testing

A Clinical Study to Test the Safety, Exposure, and Pharmacodynamic Markers of CSL311 in Patients With Mild-to-moderate Asthma and in Healthy Volunteers

Who this might be right for
Asthma
CSL Behring 78
Early research (Phase 1)Study completedNCT00557505
What this trial is testing

PF-03732010 In Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Pfizer 43
Early research (Phase 1)Not Yet RecruitingNCT07516639
What this trial is testing

First-in-Human Study of ISH0613: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics

Who this might be right for
Healthy Subjects (HS)SLE (Systemic Lupus)
SUNHO（China）BioPharmaceutical CO., Ltd. 26
Early research (Phase 1)Study completedNCT01098877
What this trial is testing

First In Human Study Of Increasing Oral Doses Of PF-04634817

Who this might be right for
Healthy
Pfizer 27
Large-scale testing (Phase 3)Study completedNCT01072331
What this trial is testing

Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Tanabe Pharma Corporation 99
Testing effectiveness (Phase 2)Ended earlyNCT03681951
What this trial is testing

First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors

Who this might be right for
Neoplasms, Pancreatic
GlaxoSmithKline 8
Early research (Phase 1)Study completedNCT04916431
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-6231 in Healthy Adults

Who this might be right for
Healthy Volunteers
ModernaTX, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT02497937
What this trial is testing

Evaluate the Effect of the Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Blocker, GSK2798745, on Pulmonary Gas Transfer and Respiration in Patients With Congestive Heart Failure

Who this might be right for
Heart Failure
GlaxoSmithKline 11
Testing effectiveness (Phase 2)Study completedNCT04417972
What this trial is testing

The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis.

Who this might be right for
Endometriosis
Jiangsu HengRui Medicine Co., Ltd. 179
Testing effectiveness (Phase 2)Study completedNCT03728634
What this trial is testing

Evaluate the Safety and Tolerability, as Well as the Pharmacokinetic and Pharmacodynamic Profiles of Single and Multiple Doses of Eplontersen Administered Subcutaneously to Healthy Volunteers and Patients With Hereditary Transthyretin-Mediated Amyloidosis (hATTR ).

Who this might be right for
Healthy VolunteershATTR Amyloidosis
Ionis Pharmaceuticals, Inc. 47
Very early researchLooking for participantsNCT07577817
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.

Who this might be right for
AnemiaIron DeficienciesChronic Kidney Disease
Cajal Therapeutics Inc. 72
Testing effectiveness (Phase 2)Study completedNCT02478060
What this trial is testing

Birch-SPIRE Safety and Efficacy Study

Who this might be right for
Rhinitis
Circassia Limited 64
Early research (Phase 1)Study completedNCT02632526
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Male Subjects

Who this might be right for
Healthy Male SubjectsCardiovascular Disease
AstraZeneca 96
Early research (Phase 1)Ended earlyNCT00060515
What this trial is testing

RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease

Who this might be right for
Mitochondrial Diseases
Repligen Corporation 12
Testing effectiveness (Phase 2)Looking for participantsNCT07010835
What this trial is testing

Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Excyte Biopharma Ltd 189
Testing effectiveness (Phase 2)Looking for participantsNCT06542250
What this trial is testing

Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Who this might be right for
B-cell Malignancies
AstraZeneca 174
Testing effectiveness (Phase 2)Study completedNCT00411424
What this trial is testing

Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Astellas Pharma Inc 54
Testing effectiveness (Phase 2)Study completedNCT00995618
What this trial is testing

Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia

Who this might be right for
GoutHyperuricemia
Nuon Therapeutics, Inc. 24
Next Page